Search Results 1411-1420 of 19927 for Receptor

1. Examining the effectiveness of gene therapy treatment for osteoarthritis - Mayo Clinic

   Identification of protein called interleukin-1 receptor antagonist (IL-1Ra) as a potential therapeutic agent in OA. · Development of vectors based on adeno- ...

2. Sleep Characteristics, Cognitive Function, Alzheimer’s Disease and Vascular Pathology Biomarkers in Cognitively Unimpaired Older Adults - Mayo Clinic

   Use of selective α1-adrenergic receptor antagonists, for example, tamsulosin (Flomax®), doxazosin (Cardura®), prazosin (Minipress®), and terazosin (Hytrin ...

3. Clinical trials - Oncology (Medical)

   This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

4. Clinical trials - Oncology (Medical)

   This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

5. Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research

   ... receptor (EGFR) and/or human epidermal growth factor receptor (HER2) mutations. The study drug, BH-30643 capsules, will be self-administered by mouth twice ...

6. MAYO CLINIC HEALTH LETTER

   Pembrolizumab is the first melanoma drug to block a cellular pathway called programmed death receptor-1 (PD-1). In a recent study involving 173 people ...

7. Low-phosphorus diet: Helpful for kidney disease? - Mayo Clinic

   See also. 10 ways to control high blood pressure without medication · Alcohol: Does it affect blood pressure? Alpha blockers · Angiotensin II receptor blockers ...

8. Clinical trials - Oncology (Medical)

   This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

9. Sym021 in Combination with Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients with Advanced Biliary Tract Carcinomas - Mayo Clinic

   Patients with known fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement, or isocitrate dehydrogenase 1 (IDH1) mutation will be excluded.

10. Clinical trials - Oncology (Medical)

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...